p-Bcl-2 Anticuerpo (A-3) recomendado para detectar Thr 74 phosphorylated Bcl-2 de human origen, mediante WB, IP, IF y ELISA

p-Bcl-2 Anticuerpo (A-3): sc-377513

p-Bcl-2 Anticuerpo (A-3) clasificado 4.0 de 5 por 1.
  • y_2021, m_9, d_18, h_20
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.19
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_es_ES, sid_377513, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 124ms
  • REVIEWS, PRODUCT
loading
5
0
4
1
3
0
2
0
1
0

Ficha técnica

    • p-Bcl-2 Anticuerpo (A-3) es un monoclonal de ratón IgG2b (kappa light chain) proporcionado como 200 µg/ml
    • recomendado para detectar Thr 74 phosphorylated Bcl-2 de human origen, mediante WB, IP, IF y ELISA
    • m-IgG2b BP-HRP is the preferred secondary detection reagent for p-Bcl-2 Antibody (A-3) for WB applications. This reagent is now offered in a bundle with p-Bcl-2 Antibody (A-3) (see ordering information below).
loading

What application is the blocking peptide sc-377513 P appropriate for?

Preguntado por: Cweed
Thank you for your question. The blocking peptide is intended for use as a negative control, by pre-adsorbing the mouse monoclonal antibody against the antigen. For full protocol details, please contact our Technical Services Department or view our online protocol here: https://www.scbt.com/scbt/resources/protocols/peptide-neutralization
Respondida por: Technical Support
Fecha de publicación: 2017-02-27
  • y_2021, m_9, d_18, h_20CST
  • bvseo_bulk, prod_bvqa, vn_bulk_3.0.19
  • cp_1, bvpage1
  • co_hasquestionsanswers, tq_1
  • loc_es_ES, sid_377513, prod, sort_[SortEntry(order=LAST_APPROVED_ANSWER_SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 129ms
  • QUESTIONS, PRODUCT
Rated 4 de 5 por de Single strong band with little background Single strong band with little background for WB in untreated, human recombinant ERK 2 treated and human recombinant ERK 2 and lambda protein phosphatase treated human recombinant Bcl-2 fusion proteins. - SCBT QC
Fecha de publicación: 2014-04-23
  • y_2021, m_9, d_18, h_20
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.19
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_es_ES, sid_377513, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 16ms
  • REVIEWS, PRODUCT